Figure 2. Overall survival (OS), leukemia-free survival (LFS) and event-free survival (EFS) for patients with CMML treated with hypomethylating agents.
(A) OS, (B) LFS and (C) EFS of the 151 CMML patients treated with hypomethylating agents.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.